{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:16:36Z","timestamp":1789665396636,"version":"4.0.1"},"reference-count":16,"publisher":"Scientific Scholar","issue":"02","license":[{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"vor","delay-in-days":175,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["South Asian J Cancer"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Objective Follicular lymphoma (FL) is a disease of the elderly. It is postulated that younger patients have distinct tumor biology and treatment outcomes. Various lymphoma groups across the world have studied this to understand if young adults (YAs) need a different treatment approach. Our study fills the void in data from an Asian country on YA population with FL.<\/jats:p>\n                  <jats:p>Patients and Methods We retrospectively analyzed young patients (age \u226440 years) diagnosed with FL at our center from 2012 to 2018. Their disease characteristics, treatment details, and outcomes were studied to examine any association between various parameters and survival.<\/jats:p>\n                  <jats:p>Results There were 28 young FL patients included in our study that constituted 14.6% of FL cases (males: 53.5% and females: 46.5%). The median age at diagnosis was 36.5 years. Most of the patients presented in an advanced stage, 57% had extranodal involvement, and 39.3% had bone marrow involvement at the time of presentation. The most common chemotherapy regimen used was cyclophosphamide, vincristine, and prednisone. Half of them received chemoimmunotherapy and only 18% continued rituximab as maintenance therapy. The overall response rate was 92.9% (n = 26), and the remaining two patients had progressive disease while on treatment. The median progression free survival (PFS) was 6.1 years and median overall survival (OS) was not reached. On univariate analysis, extranodal disease was associated with a lower PFS (p = 0.06) and low hemoglobin showed a significant association with OS (p = 0.005). On multivariate analysis, none of the factors showed a significant association with survival.<\/jats:p>\n                  <jats:p>Conclusion Most YAs present with advanced disease with a good response to treatment and favorable outcomes.<\/jats:p>","DOI":"10.1055\/s-0041-1728226","type":"journal-article","created":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T22:33:27Z","timestamp":1632436407000},"page":"115-119","source":"Crossref","is-referenced-by-count":2,"title":["Follicular Lymphoma in Young Adults: Study from a Regional Cancer Center in South India"],"prefix":"10.25259","volume":"10","author":[{"given":"A. H.","family":"Rudreshaa","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shina","family":"Goyal","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lokanatha","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linu Abraham","family":"Jacob","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. N.","family":"Lokesh","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smitha","family":"Saldanha","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bipinesh","family":"Sansar","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. K.","family":"Rajeev","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2021,9,23]]},"reference":[{"issue":"11","key":"ref1","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. The Non-Hodgkin\u2019s Lymphoma Classification Project","volume":"89","year":"1997","journal-title":"Blood"},{"issue":"26","key":"ref2","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1200\/JCO.2012.48.3990","article-title":"Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa\/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource","volume":"31","author":"B K Link","year":"2013","journal-title":"J Clin Oncol"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.clml.2011.03.001","article-title":"Treatment of indolent lymphoma in Germany - results of a representative population-based survey","volume":"11","author":"C Schmidt","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"19","key":"ref4","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1002\/cncr.27513","article-title":"Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: report from the National LymphoCare Study","volume":"118","author":"C Nabhan","year":"2012","journal-title":"Cancer"},{"issue":"05","key":"ref5","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"P Solal-C\u00e9ligny","year":"2004","journal-title":"Blood"},{"issue":"03","key":"ref6","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1200\/JCO.1997.15.3.1110","article-title":"Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d\u2019Etude des Lymphomes Folliculaires. Groupe d\u2019Etude des Lymphomes de l\u2019Adulte","volume":"15","author":"P Brice","year":"1997","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0140-6736(03)14110-4","article-title":"British National Lymphoma Investigation. Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial","volume":"362","author":"K M Ardeshna","year":"2003","journal-title":"Lancet"},{"issue":"02","key":"ref8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2141.2011.08942.x","article-title":"Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times","volume":"156","author":"B E Wahlin","year":"2012","journal-title":"Br J Haematol"},{"issue":"03","key":"ref9","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/bjh.13451","article-title":"Clinical characteristics and early treatment outcomes of follicular lymphoma in young adults","volume":"170","author":"S A Gangatharan","year":"2015","journal-title":"Br J Haematol"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1093\/annonc\/mdv376","article-title":"Life expectancy of young adults with follicular lymphoma","volume":"26","author":"A Conconi","year":"2015","journal-title":"Ann Oncol"},{"issue":"11","key":"ref11","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1093\/annonc\/mdv375","article-title":"Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study\u2020","volume":"26","author":"C Casulo","year":"2015","journal-title":"Ann Oncol"},{"issue":"06","key":"ref12","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1080\/10428190410001663680","article-title":"Survival in young patients (less than 40 years) with follicular lymphoma: a population based study by the Scotland and Newcastle Lymphoma Group","volume":"45","author":"G P Summerfield","year":"2004","journal-title":"Leuk Lymphoma"},{"issue":"23","key":"ref13","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1200\/JCO.2014.59.7534","article-title":"Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: an analysis from the National LymphoCare Study","volume":"33","author":"C Casulo","year":"2015","journal-title":"J Clin Oncol"},{"issue":"08","key":"ref14","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1093\/annonc\/mdy203","article-title":"Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials","volume":"29","author":"M J Maurer","year":"2018","journal-title":"Ann Oncol"},{"issue":"03","key":"ref15","first-page":"681","article-title":"Follicular lymphoma: an institutional analysis","volume":"18","author":"A Gogia","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"issue":"09","key":"ref16","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1007\/s00520-013-1809-4","article-title":"Assessing information and service needs of young adults with cancer at a single institution: the importance of information on cancer diagnosis, fertility preservation, diet, and exercise","volume":"21","author":"A A Gupta","year":"2013","journal-title":"Support Care Cancer"}],"container-title":["South Asian Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1728226.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:12:23Z","timestamp":1781176343000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.sajc.org\/follicular-lymphoma-in-young-adults-study-from-a-regional-cancer-center-in-south-india\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":16,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2021,9,23]]},"published-print":{"date-parts":[[2021,4]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1728226","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2278-330X","2278-4306"],"issn-type":[{"value":"2278-330X","type":"print"},{"value":"2278-4306","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}